Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

Investor’s Corner shines a light on innovative technologies and solutions with high market potential With over two-thirds of ...

Numerous private clinics claim to offer miraculous cures for hard-to-treat medical conditions, even though their treatments ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

Researchers have developed a non-addictive painkiller that remains inactive until it reaches sites of chronic pain. Instead of dulling the nerves that send the pain signals like other analgesics, this ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo ...

GNSC-001 is an investigational, adeno-associated virus gene therapy expressing an optimized form of IL-1Ra. The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for ...

A 5-gram tube of Zovirax cream runs more than $200. A month’s supply of valacyclovir (500 milligrams) tablets costs between ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...